Decorative image

Mirena coil contraceptive after cancer

The Mirena coil is a type of contraception for women. Some women should not use a Mirena coil after cancer treatment.

What the Mirena coil is

The Mirena coil is an intrauterine system (IUS). And although it is similar to a contraceptive coil (IUD) it works in a different way.

You have the Mirena coil put into your womb like the contraceptive coil. But unlike the contraceptive coil, it releases a small amount of a man made hormone into your womb every day. This is levonorgestrel – a man made version of the hormone progesterone. It helps to prevent pregnancy in 2 ways:

  • by thickening the mucus at the neck of the womb making it difficult for sperm to enter the womb
  • by stopping the womb lining from thickening making it difficult for fertilised eggs to settle in the womb

Because the lining of the womb doesn’t thicken, you may have much lighter periods. Or your periods may stop completely. In fact, some women have this type of coil put in to help make heavy periods lighter.

Who shouldn’t use the Mirena coil

The manufacturers of the Mirena coil say that women shouldn’t use it if they have had:

  • cervical cancer or womb cancer
  • liver cancer
  • hormone dependent cancers, including breast cancer
  • blood cancers, including leukaemia
  • gestational trophoblastic tumours, such as molar pregnancy

Liver cancer

The Mirena coil may affect how your liver works. If you have had liver cancer or any type of liver disease, you should not use the Mirena coil.

Hormone dependent cancers, including breast cancer

Although the Mirena coil only releases a small amount of levonorgestrel, we are not sure how much of it, if any, goes to other parts of the body.

Currently, there is no strong evidence to show whether or not the Mirena coil could cause cancers that depend on hormones to grow.

Although a couple of studies have found a link between this type of coil and breast cancer, they had flaws. For example, they did not account for factors that we know are linked to a woman's risk of breast cancer such as weight and family history.

Overall there does not appear to be a link between using an IUS device and breast cancer. But if you are concerned you can talk to your GP or specialist about what contraception is best for you.

Blood cancers, including leukaemia

If you have a blood cancer such as leukaemia and have a Mirena coil, any bleeding caused by the coil would be much heavier. This is because you may not have enough platelets to help your blood clot normally.

The manufacturers of the Mirena coil say it may be used with caution if your leukaemia is in remission.

Gestational trophoblastic tumours, such as molar pregnancy

The manufacturers recommend that you do not use the Mirena coil if you have recently been diagnosed with a gestational trophoblastic tumour (GTT), such as a molar pregnancy or choriocarcinoma. They say you should not use this type of coil while your HCG levels are still raised.

Your specialist will advise you about this.

Last reviewed: 
24 Mar 2015
  • A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well

    HK Lyytinen and others

    International Journal of Cancer, 2010

    Volume 126, Issue 2

  • British National Formulary

    Accessed 2015

  • Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland

    T Soini and others

    Obstetrics and Gynacology, 2014

    Volume 124

  • Electronic Medicines Compendium

    Accessed 2015

  • Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer

    J Dinger and others

    Contraception, 2011

    Volume 83, Issue 3

  • Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?

    G Boutet

    Gynécologie Obstétrique & Fertilité, 2006

    Volume 34, Issue 11,

  • Use of the levonorgestrel-releasing intrauterine system and breast cancer

    T Backman and others

    Obstetrics and Gynaecology, 2005

    Volume 106, Issue 4

     

Information and help

Dangoor sponsorship

About Cancer generously supported by Dangoor Education since 2010.